期刊文献+

P16蛋白表达与胃癌及淋巴结转移的关系 被引量:3

Expression of P16 Oncoprotein in Human Gastric Garcinoma and Metastatic Lymph Node
在线阅读 下载PDF
导出
摘要 目的 :前瞻性研究抑癌基因P1 6蛋白在人胃癌及转移淋巴结中的表达与胃癌转移的关系。方法 :应用SP免疫组织化学方法检测 46例原发性胃癌及 6 9枚转移淋巴结中P1 6蛋白表达。结果 :P1 6蛋白在受检原发性胃癌中的阳性率分别为 1 7.4% (8/46 ) ,在转移淋巴结中的阳性率分别为 1 5 .9% (1 1 /6 9)。原发癌伴淋巴结转移组P1 6的阳性表达率 (6 .9% )低于不伴淋巴结转移组的阳性率 (3 5 .3 % ) ,差异有显著性 (P <0 .0 5 )。P1 6表达与肿瘤大小、部位、浸润深度、Bormann分型、年龄及性别等因素无相关性(P >0 .0 5 )。P1 6在原发性胃癌及转移淋巴结中的表达无相关性 (P >0 .0 5 )。结论 :P1 6基因蛋白对胃癌的发展及淋巴结转移有抑制作用。检测胃癌P1 6蛋白对评估胃癌生物学行为、预测胃癌淋巴结转移以及预后可能具有一定的价值。 Objective: To study the role of the P16 oncoproteins in development of human gastric carcinomaand lymph node metastasis prespectively. Methods: The expression of P16 in 46 cases of primary gastric carcinomas and 69 metastatic lymph nodes was detected by SP immunohistochemical method. All samples were obtained freshly,fixed with 10% buffered formalin immediately ,embedded with parafin and then sectioned serially.Using konwn positive staining section of P16 in esophageal carcinoma as control.Results:The positive expression rates of P16 were 17.4% in primary gastric carcinomas and 15.9% in metastatic lymph nodes respectively .The positive rate of P16 in primary gastric carcinomas with lymph onde metastasis was lower than that in ones without lymph node metastasis(P<0.05).No correlations was found between the expressions of P16 in primary gastric carcinomas and metastatic lymph nodes.Conclusions:The P16 oncoproteins might play an important role in suppression of gastric carcinoma metastasis.the detection of P16 oncoproteins might reflect the the biological behaiour,lymphatic metastasis and prognosis of gastriccarcinoma.
出处 《长治医学院学报》 2001年第3期161-163,共3页 Journal of Changzhi Medical College
关键词 胃癌 抑癌基因 P16 免疫组织化学 转移淋巴结 gastric carcinoma Tumor supressor gene P16 Immunohistochemistry Metastatic lymph node
  • 相关文献

参考文献1

  • 1同济医科大学 中山医科大学病理教研室.外科病理学(第2版)[M].武汉:湖北科学技术出版社,1999.781.

共引文献12

同被引文献56

  • 1陆哲明.p16抑癌基因的发现及研究[J].国外医学(肿瘤学分册),1995,22(6):321-323. 被引量:20
  • 2吕有勇,高崇峰,崔建涛,孙梅程,金泉.胃癌中MTS1/p16基因缺失及表达异常的研究[J].中华肿瘤杂志,1996,18(3):189-191. 被引量:88
  • 3Reed J A, Loganzo F, Shea C R, et al. loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlated with invasive stage of tumor progression[J].Cancer Res, 1995, 55(13): 2713.
  • 4Zhang Y,Xiong Y. Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53[J]. Mol Cell, 1999,3(5):579-591.
  • 5Ohta M, Nagai H, Shimizl M, et al. Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitor gene, CDK4I, in melanoma[J].Cancer Res, 1994,54 (20):5269-5272.
  • 6Travis J. Closing in on melanoma susceptibility gene(s)[J]. Science, 1992,258(5085): 1080- 1081.
  • 7Diaz M O, Rubin C M, Harden A, et al. Deletions of interferon genes in acute lymphoblastic leukemia[J].N Engl J Med, 1990,322(2):77-79.
  • 8James C D, He J, Collins V P, et al. Localization of chromosome 9P homozygous in glioma cell Lines with markers constituting a continuous linkage group[J]. Cancer Res, 1993, 53(16) :3674-3675.
  • 9Cheng J, Jhanwar S C, Lu Y, et al. Homozygous deletions within 9P21 P22 indentify a small critical region fo chromosomalloss in human malignant mesotheliomas[J].Cancer Res, 1993, 53(20):4761-4763.
  • 10Serrano M, Hannon G J, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of Cyclin D1/CDK4[J].Nature, 1993, 366(6456):704-707.

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部